Medicine recalls
|
|
Batch recall of Indapin SR Film-coated Tab 1.5mg |
|
The Department of Health (DH) today (26 November) endorsed a licensed drug wholesaler, namely Suntol Medical Limited (Suntol), to recall one batch (batch number: IDSA44A) of Indapin SR Film-coated Tab 1.5mg (Hong Kong Registration number: HK- 58173), from the market as a precautionary measure due to potential quality issue.
The DH received notification from Suntol that the overseas manufacturer of the product is recalling the above batch due to sample failed dissolution test during ongoing stability testing, which might affect the efficacy of the product. As a precautionary measure, Suntol is voluntarily recalling the above batch from the market.
The above product, containing indapamide, is a prescription medicine used for the treatment of hypertension. According to Suntol, the above batch of product has been imported into Hong Kong and supplied to private doctors and pharmacy.
Suntol has set up a hotline (2546 5699) to answer related enquiries.
So far, the DH has not received any adverse reaction reports in connection with the above batch of product. The DH will closely monitor the recall.
Patients who are taking the above product should not stop taking the medicine, but should consult their healthcare professionals as soon as possible for appropriate arrangements.
End/Tuesday, November 26, 2024
|
|